Since then, newly traded companies such as voxeljet and ExOne have dropped close to 80% of their stock value, while 3D Systems, which at one point was trading above $80, is now trading at $28.5, and Stratasys has gone from well above $120 to $61. There are more examples of 3D printing “pure players” struggling on the financial markets: Belgian 3D printing service Materialise is down from a $12 IPO price to about $8, and so is German Alphaform (from €5 to about €3) and American Protolabs (from a $80 high to $65). Organovo, the only public 3D bioprinting company, is down about 50% from its all time high of $12. SLM Solutions, which is traded on the German XETRA, and Arcam Metals, which is traded on the Swedish NASDAQ have dropped around 20% of their value since their respective highs in February and June 2014.